Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_3201	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human edwig sarcoma cell line	RD-ES	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.0001 MOI	20% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3202	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human edwig sarcoma cell line	RD-ES	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.001 MOI	10% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3203	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human edwig sarcoma cell line	RD-ES	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.01 MOI	10% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3204	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human edwig sarcoma cell line	RD-ES	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.1 MOI	10% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3205	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human edwig sarcoma cell line	RD-ES	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	1 MOI	10% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3206	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human edwig sarcoma cell line	RD-ES	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	10 MOI	10% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3231	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human bone osteosarcoma cell line	143-B	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.0001 MOI	75% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3232	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human bone osteosarcoma cell line	143-B	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.001 MOI	50% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3233	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human bone osteosarcoma cell line	143-B	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.01 MOI	30% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3234	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human bone osteosarcoma cell line	143-B	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.1 MOI	20% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3235	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human bone osteosarcoma cell line	143-B	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	1 MOI	10% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3236	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human bone osteosarcoma cell line	143-B	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	10 MOI	10% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3261	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.0001 MOI	40% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3262	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.001 MOI	40% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3263	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.01 MOI	27% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3264	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.1 MOI	22% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3265	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	1 MOI	20% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3266	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human canine osteosarcoma	D17	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	10 MOI	10% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3291	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human synovial sarcoma cell line	SW982	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.0001 MOI	100% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3292	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human synovial sarcoma cell line	SW982	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.001 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3293	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human synovial sarcoma cell line	SW982	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.01 MOI	77% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3294	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human synovial sarcoma cell line	SW982	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	0.1 MOI	60% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3295	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human synovial sarcoma cell line	SW982	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	1 MOI	25% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3296	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human synovial sarcoma cell line	SW982	90% confluence	NA	Crystal violet staining and absorbance at 595 nm	10 MOI	10% cell survival after 48 hours	No	No	NA	No response	NA	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_3297	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Murine sarcoma cell line	S180	NA	NA	NA	NA	NA	Balb/c nude mice isograft for S180 mouse tumor cell line (1.0E+6)	1.0E+8 pfu	NA	Complete regression in tumor volume after 97 days	Intratumoral	NA	Genration of memory immune response by incresing production of cytokines	NA	28568891
OV_4736	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.001 MOI	1% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4737	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.01 MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4738	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.1 MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4739	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	1 MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4740	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4741	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.001 MOI	5% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4742	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.01 MOI	4% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4743	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.1 MOI	3% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4744	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	1 MOI	3% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4745	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	1% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4746	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.001 MOI	1% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4747	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.01 MOI	1% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4748	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	5000 cells per well	NA	Cell titer Glo luminiscent assay	0.1 MOI	1% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4749	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	5000 cells per well	NA	Cell titer Glo luminiscent assay	1 MOI	1% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4750	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	1% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4775	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	50000 cells per well	NA	Cell titer Glo luminiscent assay	0.01 MOI	25% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4776	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	50000 cells per well	NA	Cell titer Glo luminiscent assay	0.1 MOI	20% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4777	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	50000 cells per well	NA	Cell titer Glo luminiscent assay	1 MOI	15% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4778	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	10% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4779	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	50000 cells per well	NA	Cell titer Glo luminiscent assay	0.01 MOI	30% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4780	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	50000 cells per well	NA	Cell titer Glo luminiscent assay	0.1 MOI	15% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4781	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	50000 cells per well	NA	Cell titer Glo luminiscent assay	1 MOI	15% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4782	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	15% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4783	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	50000 cells per well	NA	Cell titer Glo luminiscent assay	0.01 MOI	100% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4784	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	50000 cells per well	NA	Cell titer Glo luminiscent assay	0.1 MOI	80% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4785	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	50000 cells per well	NA	Cell titer Glo luminiscent assay	1 MOI	80% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4786	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR3	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	50% cell survival	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4789	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	18% cell viability after 24 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4792	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	10% cell viability after 48 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4795	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	5% cell viability after 72 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4798	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	1% cell viability after 4 days	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4801	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	2% cell viability after 5 days	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4804	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	60% cell viability after 24 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4807	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	20% cell viability after 48 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4810	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	10% cell viability after 72 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4813	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	1% cell viability after 4 days	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4816	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	2% cell viability after 5 days	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4819	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR8	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	10% cell viability after 24 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4822	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR8	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	1% cell viability after 48 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4825	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR8	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	1% cell viability after 72 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4828	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR8	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	1% cell viability after 4 days	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4831	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR8	5000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	1% cell viability after 5 days	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4834	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	60% cell viability after 24 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4837	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	10% cell viability after 48 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4840	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	5% cell viability after 72 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4843	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	1% cell viability after 4 days	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4846	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	HEYA8	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	1% cell viability after 5 days	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4849	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	80% cell viability after 24 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4852	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	40% cell viability after 48 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4855	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	10% cell viability after 72 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4858	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	20% cell viability after 4 days	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4861	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	SKOV3	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	20% cell viability after 5 days	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4864	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR8	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	100% cell viability after 24 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4867	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR8	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	70% cell viability after 48 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4870	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR8	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	30% cell viability after 72 hours	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4873	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR8	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	25% cell viability after 4 days	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_4876	Maraba virus	wild type	RNA	Rhabdoviridae	None	Yes	No	No	NA	Human ovarian cancer cell line	OVCAR8	50000 cells per well	NA	Cell titer Glo luminiscent assay	10 MOI	25% cell viability after 5 days	No	No	NA	No response	NA	NA	NA	NA	27119108
OV_5369	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Murine triple negative breast cancer cell line	4T1	NA	NA	Coomassie brilinat blue staining	4 micromolar	70% cell killing after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5370	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Murine triple negative breast cancer cell line	EMT6	NA	NA	Coomassie brilinat blue staining	4 micromolar	!00% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5371	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Murine triple negative breast cancer cell line	E0771	NA	NA	Coomassie brilinat blue staining	4 micromolar	90% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5372	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Murine triple negative breast cancer cell line	4T1	NA	NA	Coomassie brilinat blue staining	4 micromolar	10% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Impaired IFN beta production by combination	In clinical trial for various cancer cell line	27503504
OV_5373	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Murine triple negative breast cancer cell line	EMT6	NA	NA	Coomassie brilinat blue staining	4 micromolar	30% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Impaired IFN beta production by combination	In clinical trial for various cancer cell line	27503504
OV_5374	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Murine triple negative breast cancer cell line	E0771	NA	NA	Coomassie brilinat blue staining	4 micromolar	20% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Level of IFN beta production does not effected by combination	In clinical trial for various cancer cell line	27503504
OV_5375	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human triple negative breast cancer cell line	Hs578T	NA	NA	Coomassie brilinat blue staining	4 micromolar	100% cell viable after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5376	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human triple negative breast cancer cell line	BT-549	NA	NA	Coomassie brilinat blue staining	4 micromolar	80% cell viable after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5377	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human triple negative breast cancer cell line	MDA-MB-231	NA	NA	Coomassie brilinat blue staining	4 micromolar	80% cell viable after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5378	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Human triple negative breast cancer cell line	Hs578T	NA	NA	Coomassie brilinat blue staining	4 micromolar	20% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Impaired IFN beta production by combination	In clinical trial for various cancer cell line	27503504
OV_5379	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Human triple negative breast cancer cell line	BT-549	NA	NA	Coomassie brilinat blue staining	4 micromolar	20% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Impaired IFN beta production by combination	In clinical trial for various cancer cell line	27503504
OV_5380	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Human triple negative breast cancer cell line	MDA-MB-231	NA	NA	Coomassie brilinat blue staining	4 micromolar	30% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Level of IFN beta production does not effected by combination	In clinical trial for various cancer cell line	27503504
OV_5381	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	NA	NA	NA	NA	NA	NA	NA	NA	BALB/c mice isograft for 2.0E+5 4T1 cells	No	NA	Reduction in tumor volume to 400 cubic mm compared to control 800 cubic mm after 25 days and increase in survival time to 45 days compared to 40 days control	Intratumoral	Induction of apoptosis	Level of IFN beta production does not effected by combination	In clinical trial for various cancer cell line	27503504
OV_5382	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	NA	NA	NA	NA	NA	NA	NA	NA	BALB/c mice isograft for 2.0E+5 EMT6 cells	No	NA	Reduction in tumor volume to 800 cubic mm compared to control 1000 cubic mm after 18 days and increase in survival time to 30 days compared to 25 days control	Intratumoral	Induction of apoptosis	Level of IFN beta production does not effected by combination	In clinical trial for various cancer cell line	27503504
OV_5383	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	NA	NA	NA	NA	NA	NA	NA	NA	C57/Bl6 mice isograft for 1.0E+6 EO771 cells	No	NA	Reduction in tumor volume to 500 cubic mm compared to control 1200 cubic mm after 30 days and increase in survival time to 45 days compared to 32 days control	Intratumoral	Induction of apoptosis	Level of IFN beta production does not effected by combination	In clinical trial for various cancer cell line	27503504
OV_5384	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2mg/kg micromolar palcitaxel for 48 hours	No	NA	NA	NA	NA	NA	NA	NA	NA	BALB/c mice isograft for 2.0E+5 4T1 cells	No	NA	Reduction in tumor volume to 200 cubic mm compared to control 800 cubic mm after 25 days and increase in survival time to 60 days compared to 40 days control	Intratumoral	Induction of apoptosis	Level of IFN beta production does not effected by combination	In clinical trial for various cancer cell line	27503504
OV_5385	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 10mg/kg micromolar palcitaxel for 48 hours	No	NA	NA	NA	NA	NA	NA	NA	NA	BALB/c mice isograft for 2.0E+5 EMT6 cells	No	NA	Reduction in tumor volume to 400 cubic mm compared to control 1000 cubic mm after 18 days and increase in survival time to 30 days compared to 25 days control	Intratumoral	Induction of apoptosis	Level of IFN beta production does not effected by combination	In clinical trial for various cancer cell line	27503504
OV_5386	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2mg/kg micromolar palcitaxel for 48 hours	No	NA	NA	NA	NA	NA	NA	NA	NA	C57/Bl6 mice isograft for 1.0E+6 EO771 cells	No	NA	Reduction in tumor volume to 100 cubic mm compared to control 1200 cubic mm after 30 days and increase in survival time to 70 days compared to 32 days control	Intratumoral	Induction of apoptosis	Level of IFN beta production does not effected by combination	In clinical trial for various cancer cell line	27503504